Navigation Links
Maclaren Appoints New President and New Chief Operation Officer
Date:10/27/2008

aclaren Europe Limited has its headquarters at its original home in Long Buckby, England. Maclaren USA Inc. headquarters are in South Norwalk, Connecticut.

A global brand, Maclaren is pleased to support global and local charities affecting the health and well being of families through organizations including as The Hunger Project, Kids in Distressed Situations, Inc. and Baby Buggy.

Media Contacts:

Tricia Chan, Public Group LLC

T: 212.905.3260, tricia@public-group.com


'/>"/>
SOURCE Maclaren USA Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Resonant Medical Appoints New Vice President of Global Sales
6. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
7. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
8. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
9. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
10. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
11. Adlyfe Appoints Roxanne Duan as Vice President of Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Lighthouse International and EHE International un...W YORK, Jan. 8 Thousand...e New Year that urges them to take care of their v...nd graciously donated by EHE International, was cr...leader in vision healthcare. It will be on display...
(Date:1/8/2009)...likely to be deadly for women and African-American...enomenon account for only part of the differences ... counterparts, according to results published in t...esults present a stark question for doctors and pa...se upon diagnosis don,t account for all the increa...
(Date:1/8/2009)...sets stage for productive partnership , , BALTI... Recovery Coalition (MARC), a broad-based group to...d the groundwork for improving the Medicare Second...with officials from the Center for Medicare and Me...introduce MARC as an industry resource to CMS and ...
(Date:1/8/2009)...ing an eye on pets during National Glaucoma month....ary 9, 2009 -- In recognition of National Glaucoma... spreading the word and increasing awareness of an...umans.    , , ,"When eyes...Noelle McNabb, DVM, Diplomate AVCO, a board certif...
Breaking Medicine News(10 mins):Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3Health News:Why bladder cancer is deadlier for some 2Health News:Why bladder cancer is deadlier for some 3Health News:Why bladder cancer is deadlier for some 4Health News:MARC Coalition Holds Initial Meeting With CMS; Announces New Members 2Health News:Glaucoma Awareness Not Just for Humans 2Health News:Glaucoma Awareness Not Just for Humans 3
...r an urgent Food and Drug Administration assessmen...us, on Monday, but the FDA said there wasnt an imm...he sweetener may cause cancer. A new study publish... to the fact that aspartame can cause leukemia, ly...
...M), a clinical stage biopharmaceutical company dev...atment of cancer and hepatitis C virus infection, ...l designed to evaluate the safety and efficacy of ...in patients with glioblastoma multiforme (GBM), a ...
...ve agreement with Delmont Laboratory to introduce ... treats diseases of staphylococcal infection . Acc...ry will supply bulk materials and China Biopharma ... the final packaging in China. CBPC will also con...
...ined not to give up smoking because she believes t... Rouge star said that she is an occasional smoker ...the 39-year-old is sure that she will warn everyon...going to start not to get into the habit. "Yes, I...
Other Medicine News:Health News:Aspartame Probe Call Rejected by FDA 2Health News:Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial 2
(Date:1/8/2009)...reated at the initial dose in an ongoing Phase Ib ...ecline after three days , , Conference Call Tod...wire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (N...irst cohort of an ongoing Phase Ib clinical trial ...oside polymerase inhibitor. ANA598 was very well-...
(Date:1/7/2009)...everal Products in Development Based On Osteotech,...te Natural BioRegeneration; FDA Filing Anticipated...n. 7 Osteotech, Inc. (...f biologic products for regenerative healing, anno...al trial for its DuraTech(TM) BioRegeneration Matr...
(Date:1/6/2009)....Y., Jan. 6 In recent controlled s...ty of Memphis , scientists found that the patented... first and only proven ingredient to increase leve...asing blood nitrate/nitrate (NOx) in human subject...nables an increase in blood flow to the skeletal m...
(Date:1/6/2009)... France, January 6 , ... Collaboration Until,December 2011 , - Exp...e Antibody,Discovery in Ophthalmology , - ...f Allergan,Sublicenses to a Third Party , ...nounced a reinforcement,of its existing drug disc...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Dental Implants Need More Work Than Root Canals 30236 1Dental Implants Need More Work Than Root Canals 30236 2Epocrates Offers International Market Research Panel 30234 1Epocrates Offers International Market Research Panel 30234 2Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 1Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 2Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED 1077 30232 3Radius Raises Additional 2415 Million Increasing Second Private Equity Financing Round to 2482 5 Million 3463 1Radius Raises Additional 2415 Million Increasing Second Private Equity Financing Round to 2482 5 Million 3463 2
...l and Regulatory Development of Oral,Anti-Inflamma...wire-FirstCall/ -- Celgene,Corporation announced i...l anti-inflammatory candidates across a broad rang... an oral TNF,antagonist and anti-inflammatory agen...ellent side effect profile in a placebo,controlled...
...--May 22, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israe...ay data from its Phase I trial of BL-1020, the fir...for the treatment of,schizophrenia. The trial demo...demonstrated biochemical evidence of dopamine,bloc...esented the,data in a poster (Abstract 235 XX) at ...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4
...ransfer System is a patent-pending disposable, med...s simpler for the physician and their staff, and t...LipiVage™ improves upon traditional fat tran...uge, decant or expose fat cells to unnecessary han...
...Zyplast® injectable collagen implants have set...cial lines, wrinkles and scars and in providing li...ns natural collagen, require minimal procedure tim... one million people worldwide have been treated wi...
SCULPTRA™ is an injectable implant that contains microparticles of poly-L-lactic acid, a biocompatible, biodegradable, synthetic polymer from the alpha-hydroxy-acid family. SCULPTRA is reconsti
Revitol Cellulite Cream is a revolutionary scientific breakthrough for controlling unsightly cellulite and eliminating inches. Revitol Cellulite Removal Cream permits you to spot reduce in those impo
Medicine Products: